HRAS and cancer: Non-silent SNVs (2–6 per tumour) in cancer-related genes (HRAS, ALK and ATM) occurred exclusively in high-risk neuroblastomas and were clonal in a subset of patients but also spatially or temporally heterogeneous in others.